No description
-
2021 (v1)PublicationUploaded on: February 13, 2024
-
2017 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2016 (v1)Publication
The 5th European Conference on Infections in Leukaemia (ECIL-5) meeting aimed to establish evidence-based recommendations for the prophylaxis of Pneumocystis jirovecii pneumonia (PCP) in non-HIV-infected patients with an underlying haematological condition, including allogeneic HSCT recipients. Recommendations were based on the grading system...
Uploaded on: May 13, 2023 -
2016 (v1)Publication
Pneumocystis jirovecii can cause life-threatening pneumonia following treatment for haematological malignancies or after HSCT. The mortality rate of P. jirovecii pneumonia (PCP) in these patients is 30%-60%, especially after HSCT. The clinical presentation of PCP in haematology differs from that associated with HIV infection, with the disease...
Uploaded on: May 13, 2023